Federation des caisses Desjardins du Quebec’s AMAG Pharmaceuticals AMAG Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,870	Closed	-$21.6K	–	2388
2019 Q3	$21.6K	Hold	1,870	–	–	﹤0.01%	1657
2019 Q2	$18.7K	Hold	1,870	–	–	﹤0.01%	1705
2019 Q1	$24.1K	Sell	1,870 -4,144	-69%	-$61.7K	﹤0.01%	1479
2018 Q4	$91.4K	Buy	6,014 +4,144	+222%	+$79K	﹤0.01%	1147
2018 Q3	$37.4K	Sell	1,870 -20,477	-92%	-$466K	﹤0.01%	1413
2018 Q2	$436K	Buy	22,347 +9,895	+79%	+$219K	0.01%	797
2018 Q1	$251K	Buy	12,452 +9,317	+297%	+$158K	﹤0.01%	947
2017 Q4	$41.5K	Buy	3,135 +2,765	+747%	+$41.7K	﹤0.01%	1385
2017 Q3	$6.83K	Sell	370 -1,164	-76%	-$21.7K	﹤0.01%	1769
2017 Q2	$28.2K	Hold	1,534	–	–	﹤0.01%	1511
2017 Q1	$34.6K	Buy	+1,534	New	+$36.7K	﹤0.01%	1200

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's AMAG Position: Q4 2019 in Review

Federation des caisses Desjardins du Quebec sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 1,870 shares — an estimated $21.6K sold.

Federation des caisses Desjardins du Quebec first reported a position in AMAG in Q1 2017 and held it in 11 quarters. The position peaked at $436K in Q2 2018. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

Federation des caisses Desjardins du Quebec reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,870 AMAG Pharmaceuticals shares in Q4 2019, an estimated $21.6K.
Federation des caisses Desjardins du Quebec first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 11 quarters.
Federation des caisses Desjardins du Quebec's AMAG Pharmaceuticals position peaked at $436K in Q2 2018.
134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2019, filed 30 Aug 2024.